Impacts on Premiums, Enrollment If the ACA Is Modified
Ending the subsidies offered under the Affordable Care Act would sharply increase costs for consumers, according to a study from the RAND Corporation. Furthermore, without the subsidies, more than 11 million Americans will lose their health insurance.
Fast Track for Taiho Oncology's mCRC Molecule
Taiho Oncology, Inc, announced that the FDA granted Fast Track designation for an oral combination anticancer drug under investigation for the treatment of refractory metastatic colorectal cancer.
Patients Are the “Missing Piece” for ACO Success
Industry experts discussed the big issues facing accountable care organizations (ACO) at the Brookings Institute’s event, The State of Accountable Care: Evidence to Date and Next Steps, held Monday in Washington, DC.
Myriad’s Prostate Cancer Test Receives Draft Medicare Coverage
Myriad Genetics, Inc., announced today that the Medicare Administrative Contractor (MAC) that has jurisdiction over most molecular diagnostic tests has issued its draft notice on how Medicare will provide reimbursement for Prolaris, a test that Myriad has developed to guide treatment decisions in prostate cancer.